Jane Street
ORGS

Jane Street’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Jane Street’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,200
Closed -$6.01K – 10290
2023
Q4 		$6.01K Buy
+1,200
New +$7.69K ﹤0.01% 9004
2020
Q3 		– Sell
-2,309
Closed -$140K – 8098
2020
Q2 		$140K Buy
+2,309
New +$140K ﹤0.01% 6577

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jane Street's ORGS Position: Q1 2024 in Review

Jane Street sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2024, closing a stake of 1,200 shares — an estimated $6.01K sold.

Jane Street first reported a position in ORGS in Q2 2020 and held it in 2 quarters. The position peaked at $140K in Q2 2020. 16 funds tracked by Wall St. Rank hold ORGS as of Q1 2024.

  • Jane Street reported no remaining Orgenesis Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 1,200 Orgenesis Inc. Common Stock shares in Q1 2024, an estimated $6.01K.
  • Jane Street first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Jane Street's Orgenesis Inc. Common Stock position peaked at $140K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.